199 related articles for article (PubMed ID: 19233132)
1. Distinct parts of leukotriene C(4) synthase interact with 5-lipoxygenase and 5-lipoxygenase activating protein.
Strid T; Svartz J; Franck N; Hallin E; Ingelsson B; Söderström M; Hammarström S
Biochem Biophys Res Commun; 2009 Apr; 381(4):518-22. PubMed ID: 19233132
[TBL] [Abstract][Full Text] [Related]
2. Identification of regions of leukotriene C4 synthase which direct the enzyme to its nuclear envelope localization.
Svartz J; Hallin E; Shi Y; Söderström M; Hammarström S
J Cell Biochem; 2006 Aug; 98(6):1517-27. PubMed ID: 16552728
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological cross-reactivity between 5-lipoxygenase-activating protein, 5-lipoxygenase, and leukotriene C4 synthase.
Gupta N; Nicholson DW; Ford-Hutchinson AW
Can J Physiol Pharmacol; 1997; 75(10-11):1212-9. PubMed ID: 9431445
[TBL] [Abstract][Full Text] [Related]
4. Fetal hepatic expression of 5-lipoxygenase activating protein is confined to colonizing hematopoietic cells.
Strid T; Karlsson C; Söderström M; Zhang J; Qian H; Sigvardsson M; Hammarström S
Biochem Biophys Res Commun; 2009 Jun; 383(3):336-9. PubMed ID: 19358825
[TBL] [Abstract][Full Text] [Related]
5. 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes.
Woods JW; Evans JF; Ethier D; Scott S; Vickers PJ; Hearn L; Heibein JA; Charleson S; Singer II
J Exp Med; 1993 Dec; 178(6):1935-46. PubMed ID: 8245774
[TBL] [Abstract][Full Text] [Related]
6. Increased 5-lipoxygenase activating protein in immune-mediated experimental nephritis.
Montero A; Uda S; Kelavkar U; Yoshimura A; Badr KF; Munger KA
J Nephrol; 2003; 16(5):682-90. PubMed ID: 14733414
[TBL] [Abstract][Full Text] [Related]
7. BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly.
Garscha U; Voelker S; Pace S; Gerstmeier J; Emini B; Liening S; Rossi A; Weinigel C; Rummler S; Schubert US; Scriba GK; Çelikoğlu E; Çalışkan B; Banoglu E; Sautebin L; Werz O
Biochem Pharmacol; 2016 Nov; 119():17-26. PubMed ID: 27592027
[TBL] [Abstract][Full Text] [Related]
8. 5-Lipoxygenase upregulation by dexamethasone in human mast cells.
Colamorea T; Di Paola R; Macchia F; Guerrese MC; Tursi A; Butterfield JH; Caiaffa MF; Haeggström JZ; Macchia L
Biochem Biophys Res Commun; 1999 Nov; 265(3):617-24. PubMed ID: 10600470
[TBL] [Abstract][Full Text] [Related]
9. Expression of leukotriene biosynthetic enzymes in tonsillar tissue of children with obstructive sleep apnea: a prospective nonrandomized study.
Tsaoussoglou M; Hatzinikolaou S; Baltatzis GE; Lianou L; Maragozidis P; Balatsos NA; Chrousos G; Kaditis AG
JAMA Otolaryngol Head Neck Surg; 2014 Oct; 140(10):944-50. PubMed ID: 25211287
[TBL] [Abstract][Full Text] [Related]
10. Hyperoxia increases protein mass of 5-lipoxygenase and its activating protein, flap, and leukotriene B(4) output in newborn rat lungs.
Hosford GE; Koyanagi KS; Leung WI; Olson DM
Exp Lung Res; 2002 Dec; 28(8):671-84. PubMed ID: 12490039
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein.
Ferguson AD; McKeever BM; Xu S; Wisniewski D; Miller DK; Yamin TT; Spencer RH; Chu L; Ujjainwalla F; Cunningham BR; Evans JF; Becker JW
Science; 2007 Jul; 317(5837):510-2. PubMed ID: 17600184
[TBL] [Abstract][Full Text] [Related]
12. Cellular oxygenation of 12-hydroxyeicosatetraenoic acid and 15-hydroxyeicosatetraenoic acid by 5-lipoxygenase is stimulated by 5-lipoxygenase-activating protein.
Mancini JA; Waterman H; Riendeau D
J Biol Chem; 1998 Dec; 273(49):32842-7. PubMed ID: 9830031
[TBL] [Abstract][Full Text] [Related]
13. An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis.
Gerstmeier J; Weinigel C; Barz D; Werz O; Garscha U
Biochim Biophys Acta; 2014 Sep; 1840(9):2961-9. PubMed ID: 24905297
[TBL] [Abstract][Full Text] [Related]
14. What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases.
Evans JF; Ferguson AD; Mosley RT; Hutchinson JH
Trends Pharmacol Sci; 2008 Feb; 29(2):72-8. PubMed ID: 18187210
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of the 5-lipoxygenase pathway in atherosclerosis.
Bäck M
Curr Pharm Des; 2009; 15(27):3116-32. PubMed ID: 19754386
[TBL] [Abstract][Full Text] [Related]
16. Induction of leukotriene C4 synthase after the differentiation of rat basophilic leukemia cells with retinoic acid and a low dose of actinomycin D and its suppression with methylprednisolone.
Abe M; Shibata K; Urata H; Sakata N; Katsuragi T
J Cell Physiol; 2003 Jul; 196(1):154-64. PubMed ID: 12767051
[TBL] [Abstract][Full Text] [Related]
17. The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products.
Fischer L; Hornig M; Pergola C; Meindl N; Franke L; Tanrikulu Y; Dodt G; Schneider G; Steinhilber D; Werz O
Br J Pharmacol; 2007 Oct; 152(4):471-80. PubMed ID: 17704828
[TBL] [Abstract][Full Text] [Related]
18. IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils.
Cowburn AS; Holgate ST; Sampson AP
J Immunol; 1999 Jul; 163(1):456-65. PubMed ID: 10384149
[TBL] [Abstract][Full Text] [Related]
19. Cell biology of the 5-lipoxygenase pathway.
Peters-Golden M
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S227-31; discussion S231-2, S247-8. PubMed ID: 9647604
[TBL] [Abstract][Full Text] [Related]
20. 5-Lipoxygenase activity in the human pancreas.
Mancini JA; Li C; Vickers PJ
J Lipid Mediat; 1993 Nov; 8(3):145-50. PubMed ID: 8268460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
